Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Terminated 2Completed 2

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4Head & Neck 2

Conditions

Breast Neoplasms 48Neoplasm Metastasis 4Hereditary Sensory and Autonomic Neuropathies 4Triple Negative Breast Neoplasms 3Ovarian Neoplasms 3Neoplasms 3Hyperglycemia 3Multiple Endocrine Neoplasia Type 1 2Advanced Breast Cancer 2Sarcoma 1Recurrence 1Prostatic Neoplasms 1Pre-menopausal Breast Cancer 1Pancreatic Neoplasms 1Melanoma 1Kidney Neoplasms 1Hormone Receptor Positive Breast Carcinoma 1Head and Neck Neoplasms 1HER2-positive Metastatic Breast Cancer 1Genetic Diseases, Inborn 1Gastrointestinal Neoplasms 1Exanthema 1Endometrial Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Ductal, Breast 1Anatomic Stage III Breast Cancer AJCC v8 1Advanced or Metastatic ER+ Breast Cancer 1Advanced Solid Tumors With an Alteration of the PIK3CA Gene 1Advanced HER2+Breast Cancer 1

Interventions

Fulvestrant 10Letrozole 4Alpelisib 4ribociclib 3palbociclib 3Paclitaxel 2NVP-BKM120 2volagidemab 1serabelisib 1sapanisertib 1olaparib 1liposomal doxorubicin 1gedatolisib 1exemestane 1dapagliflozin 1capivasertib 1abemaciclib 1Taxes 1Tamoxifen 1Secretin 1STX-478 1Metformin 1Lomustine 1Leuprolide 1Irinotecan 1Imlunestrant 1Goserelin 1Gemcitabine 1Drug Therapy 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Hereditary Sensory and Autonomic Neuropathies × Alpelisib × Breast × Clear all
NCT03056755 2026-01-13

BYLieve

Novartis

Phase 2 Completed
383 enrolled 16 charts
Breast

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT04899349 2024-10-09

EPIK-B4

Novartis

Phase 2 Terminated
2 enrolled 8 charts
Breast

Breast Neoplasms, Hyperglycemia, Hereditary Sensory and Autonomic Neuropathies

NCT03439046 2024-08-01

BioItaLEE

Novartis

Phase 3 Completed
287 enrolled
Breast

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT03386162 2022-11-28

SAFIR-PI3K

UNICANCER

Phase 2 Terminated
31 enrolled
Breast

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡